ALEMBIC PHARMACEUTICALS
|
ALEMBIC PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹5,653 Cr | ₹5,306 Cr | ₹5,393 Cr | ₹4,606 Cr | ₹3,935 Cr |
Sales | ₹5,500 Cr | ₹5,232 Cr | ₹5,276 Cr | ₹4,492 Cr | ₹3,807 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹25 Cr | ₹15 Cr | ₹18 Cr | - | ₹32 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹128 Cr | ₹59 Cr | ₹99 Cr | ₹114 Cr | ₹96 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹5,653 Cr | ₹5,306 Cr | ₹5,393 Cr | ₹4,606 Cr | ₹3,935 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹79 Cr | ₹-43 Cr | ₹-194 Cr | ₹-211 Cr | ₹-92 Cr |
Raw Material Consumed | ₹1,630 Cr | ₹1,490 Cr | ₹1,451 Cr | ₹1,250 Cr | ₹1,085 Cr |
Opening Raw Materials | ₹456 Cr | ₹384 Cr | ₹294 Cr | ₹347 Cr | ₹186 Cr |
Purchases Raw Materials | ₹1,184 Cr | ₹1,200 Cr | ₹1,276 Cr | ₹978 Cr | ₹964 Cr |
Closing Raw Materials | ₹390 Cr | ₹456 Cr | ₹384 Cr | ₹346 Cr | ₹300 Cr |
Other Direct Purchases / Brought in cost | ₹380 Cr | ₹361 Cr | ₹266 Cr | ₹271 Cr | ₹235 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹152 Cr | ₹121 Cr | ₹119 Cr | ₹102 Cr | ₹89 Cr |
Electricity & Power | ₹152 Cr | ₹121 Cr | ₹119 Cr | ₹102 Cr | ₹89 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹1,169 Cr | ₹1,133 Cr | ₹1,051 Cr | ₹906 Cr | ₹747 Cr |
Salaries, Wages & Bonus | ₹1,072 Cr | ₹1,045 Cr | ₹966 Cr | ₹832 Cr | ₹689 Cr |
Contributions to EPF & Pension Funds | ₹68 Cr | ₹60 Cr | ₹54 Cr | ₹51 Cr | ₹37 Cr |
Workmen and Staff Welfare Expenses | ₹29 Cr | ₹28 Cr | ₹31 Cr | ₹24 Cr | ₹21 Cr |
Other Employees Cost | - | - | - | - | - |
Other Manufacturing Expenses | ₹409 Cr | ₹379 Cr | ₹372 Cr | ₹368 Cr | ₹269 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹51 Cr | ₹19 Cr | ₹22 Cr | ₹18 Cr | ₹20 Cr |
Repairs and Maintenance | ₹66 Cr | ₹52 Cr | ₹83 Cr | ₹51 Cr | ₹38 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹293 Cr | ₹308 Cr | ₹267 Cr | ₹300 Cr | ₹211 Cr |
General and Administration Expenses | ₹493 Cr | ₹414 Cr | ₹391 Cr | ₹340 Cr | ₹341 Cr |
Rent , Rates & Taxes | ₹17 Cr | ₹15 Cr | ₹14 Cr | ₹15 Cr | ₹28 Cr |
Insurance | ₹19 Cr | ₹18 Cr | ₹13 Cr | ₹7.50 Cr | ₹6.13 Cr |
Printing and stationery | - | - | - | - | - |
Professional and legal fees | ₹210 Cr | ₹191 Cr | ₹198 Cr | ₹147 Cr | ₹137 Cr |
Traveling and conveyance | ₹171 Cr | ₹126 Cr | ₹108 Cr | ₹132 Cr | ₹134 Cr |
Other Administration | ₹246 Cr | ₹189 Cr | ₹167 Cr | ₹170 Cr | ₹169 Cr |
Selling and Distribution Expenses | ₹952 Cr | ₹890 Cr | ₹687 Cr | ₹531 Cr | ₹590 Cr |
Advertisement & Sales Promotion | ₹681 Cr | ₹634 Cr | ₹502 Cr | ₹398 Cr | ₹471 Cr |
Sales Commissions & Incentives | - | - | - | - | - |
Freight and Forwarding | ₹271 Cr | ₹256 Cr | ₹186 Cr | ₹133 Cr | ₹120 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹61 Cr | ₹48 Cr | ₹35 Cr | ₹104 Cr | ₹51 Cr |
Bad debts /advances written off | ₹6.35 Cr | ₹5.24 Cr | ₹0.19 Cr | ₹0.48 Cr | ₹13 Cr |
Provision for doubtful debts | - | ₹7.30 Cr | ₹6.06 Cr | ₹8.55 Cr | ₹3.74 Cr |
Losson disposal of fixed assets(net) | ₹4.70 Cr | - | - | - | - |
Losson foreign exchange fluctuations | ₹0.09 Cr | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹50 Cr | ₹35 Cr | ₹29 Cr | ₹95 Cr | ₹34 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹4,945 Cr | ₹4,432 Cr | ₹3,913 Cr | ₹3,392 Cr | ₹3,079 Cr |
Operating Profit (Excl OI) | ₹708 Cr | ₹874 Cr | ₹1,480 Cr | ₹1,214 Cr | ₹856 Cr |
Other Income | ₹3.04 Cr | ₹50 Cr | ₹87 Cr | ₹14 Cr | ₹27 Cr |
Interest Received | ₹0.33 Cr | ₹1.73 Cr | ₹1.58 Cr | ₹1.73 Cr | ₹2.58 Cr |
Dividend Received | - | - | - | ₹0.01 Cr | ₹2.12 Cr |
Profit on sale of Fixed Assets | - | ₹0.54 Cr | ₹1.39 Cr | ₹1.16 Cr | ₹1.18 Cr |
Profits on sale of Investments | ₹0.61 Cr | ₹2.87 Cr | ₹4.95 Cr | ₹0.92 Cr | ₹1.57 Cr |
Provision Written Back | - | - | - | - | - |
Foreign Exchange Gains | - | ₹44 Cr | ₹77 Cr | ₹8.46 Cr | ₹17 Cr |
Others | ₹2.10 Cr | ₹1.04 Cr | ₹2.28 Cr | ₹1.60 Cr | ₹2.21 Cr |
Operating Profit | ₹711 Cr | ₹925 Cr | ₹1,568 Cr | ₹1,228 Cr | ₹883 Cr |
Interest | ₹50 Cr | ₹18 Cr | ₹16 Cr | ₹27 Cr | ₹18 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | - | - | - | - | - |
Other Interest | ₹50 Cr | ₹18 Cr | ₹16 Cr | ₹27 Cr | ₹18 Cr |
PBDT | ₹661 Cr | ₹907 Cr | ₹1,552 Cr | ₹1,201 Cr | ₹865 Cr |
Depreciation | ₹275 Cr | ₹287 Cr | ₹183 Cr | ₹157 Cr | ₹115 Cr |
Profit Before Taxation & Exceptional Items | ₹386 Cr | ₹620 Cr | ₹1,368 Cr | ₹1,043 Cr | ₹749 Cr |
Exceptional Income / Expenses | - | - | - | ₹-44 Cr | - |
Profit Before Tax | ₹355 Cr | ₹625 Cr | ₹1,368 Cr | ₹1,000 Cr | ₹749 Cr |
Provision for Tax | ₹13 Cr | ₹104 Cr | ₹253 Cr | ₹199 Cr | ₹157 Cr |
Current Income Tax | ₹4.20 Cr | ₹129 Cr | ₹255 Cr | ₹205 Cr | ₹178 Cr |
Deferred Tax | ₹9.20 Cr | ₹-23 Cr | ₹-9.56 Cr | ₹-4.30 Cr | ₹-17 Cr |
Other taxes | ₹-0.79 Cr | ₹-1.25 Cr | ₹7.41 Cr | ₹-1.09 Cr | ₹-4.10 Cr |
Profit After Tax | ₹342 Cr | ₹521 Cr | ₹1,115 Cr | ₹801 Cr | ₹593 Cr |
Extra items | - | - | - | - | - |
Minority Interest | - | - | - | ₹28 Cr | ₹1.08 Cr |
Share of Associate | - | - | ₹32 Cr | ₹0.06 Cr | ₹-9.28 Cr |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹342 Cr | ₹521 Cr | ₹1,147 Cr | ₹829 Cr | ₹584 Cr |
Adjustments to PAT | - | - | - | - | ₹-1.92 Cr |
Profit Balance B/F | ₹2,554 Cr | ₹2,385 Cr | ₹1,559 Cr | ₹1,287 Cr | ₹937 Cr |
Appropriations | ₹2,896 Cr | ₹2,906 Cr | ₹2,706 Cr | ₹2,116 Cr | ₹1,519 Cr |
General Reserves | ₹-869 Cr | - | ₹250 Cr | ₹200 Cr | ₹100 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | ₹12 Cr | - |
Other Appropriation | ₹197 Cr | ₹351 Cr | ₹71 Cr | ₹176 Cr | ₹133 Cr |
Equity Dividend % | ₹400.00 | ₹500.00 | ₹700.00 | ₹500.00 | ₹275.00 |
Earnings Per Share | ₹17.40 | ₹26.50 | ₹58.33 | ₹43.97 | ₹31.00 |
Adjusted EPS | ₹17.40 | ₹26.50 | ₹58.33 | ₹43.97 | ₹31.00 |
Compare Income Statement of peers of ALEMBIC PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALEMBIC PHARMACEUTICALS | ₹18,441.1 Cr | 3% | -8.2% | 93.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,311.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹108,623.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,134.3 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹97,408.4 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,794.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALEMBIC PHARMACEUTICALS | 3% |
-8.2% |
93.9% |
SENSEX | -2.6% |
-0% |
21% |
You may also like the below Video Courses